ST-segment depression as a risk factor in hypertrophic cardiomyopathy

Europace

Volumn 11, Issue 5, 2009, Pages 643-649

  Haghjoo, Majid ^a   Mohammadzadeh, Shabnam ^a   Taherpour, Mehdi ^a   Faghfurian, Babak ^a   Fazelifar, Amir Farjam ^a   Alizadeh, Abolfath ^a   Rad, Mohammad Asadian ^a   Sadr Ameli, Mohammad Ali ^a  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Electrocardiography; Hypertrophic cardiomyopathy; Prognosis; Risk stratification

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CHILD; DEFIBRILLATOR; DOPPLER ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM ENLARGEMENT; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART RHYTHM; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE TACHYCARDIA; HOSPITAL ADMISSION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PR INTERVAL; PRIORITY JOURNAL; PROGNOSIS; Q WAVE; QRS COMPLEX; QT INTERVAL; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; ST SEGMENT DEPRESSION; SUDDEN DEATH; SYNCOPE; T WAVE INVERSION; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADOLESCENT; ADULT; AGED; ALGORITHMS; CARDIOMYOPATHY, HYPERTROPHIC; CHILD; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 66749188751     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eun393     Document Type: Article

References (33)

1. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA 2002;287: 1308-20.
2. Spirito P, Bellone P, Harris KM, Bernabo P, Bruzzi P, Maron BJ. Magnitude of left ventricular hypertrophy predicts the risk of sudden death in hypertrophic cardi-omyopathy. N Engl J Med 2000;342:1778-85.
3. Cecchi F, Olivotto I, Lazzeroni E, Chiriatti G, Sachero A, Beretta L et al. Clinical course of hypertrophic cardiomyopathy in a non-selected population. The Experience of the Italian Multicenter Cardiomyopathy Study. G Ital Cardiol 1997;27:1133-43.
4. Olivotto I, Maron BJ, Montereggi A, Mazzuoli F, Dolara A, Cecchi F. Prognostic value of systemic blood pressure response during exercise in a community-based patient population with hypertrophic cardiomyopathy. J Am Coll Cardiol 1999;33: 2044-51.
5. Maron BJ, Savage DD, Wolfson JK, Epstein SE. Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardi-omyopathy: a prospective study. Am J Cardiol 1981;48:252-7.
6. Maron BJ, Cecchi F, McKenna WJ. Risk factors and stratification for sudden cardiac death in patients with hypertrophic cardiomyopathy. Br Heart J 1994;72: S13-8.
7. Cecchi F, Olivotto I, Montereggi A, Squillatini G, Dolara A, Maron BJ. Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodar-one treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population. Heart 1998;79:331-6.
8. Fananapazir L, Chang AC, Epstein SE, McAreavey D. Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings. Circulation 1992;86:730-40.
9. Sadoul N, Prasad K, Elliott PM, Bannerjee S, Frenneaux MP, McKenna WJ. Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy. Circulation 1997;96:2987-91.
10. Elliott PM, Poloniecki J, Dickie S, Sharma S, Monserrat L, Varnava A et al. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol 2000;36:2212-8.
11. Maron BJ, Wolfson JK, CirÓ E, Spirito P. Relation of electrocardiographic abnormalities and patterns of left ventricular hypertrophy identified by 2-dimensional echocardiography in patients with hypertrophic cardiomyopathy. Am J Cardiol 1983;51:189-94.
12. Savage DD, Seides SF, Clark CE, Henry WL, Maron BJ, Robinson FC et al. Electrocardiographic findings in patients with obstructive and nonobstructive hyper-trophic cardiomyopathy. Circulation 1978;58:402-8.
13. Engler RL, Smith P, LeWinter M, Gosink B, Johnson A. The electrocardiogram in asymmetric septal hypertrophy. Chest 1979;75:167-73.
14. Ryan MP, Cleland JG, French JA, Joshi J, Choudhury L, Chojnowska L et al. The standard electrocardiogram as a screening test for hypertrophic cardiomyopathy. Am J Cardiol 1995;76:689-94.
15. Konno T, Shimizu M, Ino H, Fujino N, Hayashi K, Uchiyama K et al. Phenotypic differences between electrocardiographic and echocardiographic determination of hypertrophic cardiomyopathy in genetically affected subjects. J Intern Med 2005;258:216-24.
16. Maron BJ, McKenna WJ, Danielson GK, Kuhn HJ, Seidman CE, Shah PM et al. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A Report of the American College of Cardiology Foundation Task Force on the Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines Committee. J Am Coll Cardiol 2003;42: 1687-713.
17. Willems JL, Robles de Medina EO, Bernard R, Coumel P, Fisch C, Krikler D et al. Criteria for intraventricular conduction disturbances and pre-excitation. World Health Organizational/International Society and Federation for Cardiology Task Force Ad Hoc. J Am Coll Cardiol 1985;5:1261- 75.
18. Konno T, Shimizu M, Ino H, Fujino N, Hayashi K, Uchiyama K et al. Differences in diagnostic value of four electrocardiographic voltage criteria for hypertrophic car-diomyopathy in a genotyped population. Am J Cardiol 2005;96:1308-12.
19. Konno T, Shimizu M, Ino H, Yamaguchi M, Terai H, Uchiyama K et al. Diagnostic value of abnormal Q waves for identification of preclinical carriers of hypertrophic cardio-myopathy based on a molecular genetic diagnosis. Eur Heart J 2004;25:246-51.
20. Konno T, Fujino N, Hayashi K, Uchiyama K, Masuta E, Katoh H et al. Differences in the diagnostic value of various criteria of negative T waves for hypertrophic car-diomyopathy based on a molecular genetic diagnosis. Clin Sci (Lond) 2007;112: 577-82.
21. Maron MS, Olivotto I, Betocchi S, Casey SA, Lesser JR, Losi MA et al. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med 2003;348:295-303.
22. Maron BJ, Olivotto I, Spirito P, Casey SA, Bellone P, Gohman TE et al. Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population. Circulation 2000;102:858-64.
23. Priori SG, Aliot E, Blomstrom-Lundqvist C, Bossaert L, Breithardt G, Brugada P et al. Task force on sudden death of the European Society of Cardiology. Eur Heart J 2001;22:1374-450.
24. Charron P, Dubourg O, Desnos M, Isnard R, Hagege A, Millaire A et al. Diagnostic value of electrocardiography and echocardiography for familial hypertrophic car-diomyopathy in a genotyped adult population. Circulation 1997;96:214-9.
25. Montgomery JV, Harris KM, Casey SA, Zenovich AG, Maron BJ. Relation of elec-trocardiographic patterns to phenotypic expression and clinical outcome in hypertrophic cardiomyopathy. Am J Cardiol 2005;96:270-5.
26. Maron BJ, Shen W-K, Link MS, Epstein AE, Almquist AK, Daubert JP et al. Efficacy of implantable cardioverter-defibrillator s for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 2000;342: 365-73.
27. Shirani J, Pick R, Roberts WC, Maron BJ. Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death. J Am Coll Cardiol 2000;35:36-44.
28. Haley JH, Miller TD. Myocardial ischemia on thallium scintigraphy in hypertrophic cardiomyopathy: predictor of sudden cardiac death. Circulation 2001;104:E71.
29. Cecchi F, Olivotto I, Gistri R, Lorenzoni R, Chiriatti G, Camici PG. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med 2003;349:1027-35.
30. McKenna W, Deanfield J, Faruqui A, England D, Oakley C, Goodwin J. Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features. Am J Cardiol 1981;47:532-8.
31. Pelliccia F, Cianfrocca C, Cristofani R, Romeo F, Reale A. Electrocardiographic findings in patients with hypertrophic cardiomyopathy. Relation to presenting features and prognosis. J Electrocardiol 1990;23:213-22.
32. Lazzeri C, Barletta G, Badia T, Capalbio A, Del Bene R, Franchi F et al. Multipara-metric electrocardiographic evaluation of left ventricular hypertrophy in idio-pathic and hypertensive cardiomyopathy. Ital Heart J 2005;6:304-10.
33. Bayrak F, Kahveci G, Mutlu B, Deǧertekin M, Demirtaş E. Usefulness of surface electrocardiogram in predicting the clinical course of patients with hypertrophic cardiomyopathy. Anadolu Kardiyol Derg 2007;7:178-81.